Text Size
Donate
  • Home
  • About Us
    • Mission Statement
    • Who We Are
    • Board of Directors
    • Science Advisory Board
    • Patient Advisory Board
    • Staff
  • The Basics
    • What is CCSVI
    • CCSVI Introduction Video
    • Diagnostic Approaches
    • Known Venous Problems
    • FAQs
    • History and Timeline
    • CCSVI Multimedia
      • Video Gallery
      • Photo Gallery
    • Glossary
  • Advanced Topics
    • Articles Database
    • The Great Debate: CCSVI and MS
    • Treatment and Efficacy
    • Treatment Risks
    • Addressing the Myths
    • Research Analysis
  • Helping Myself
    • Discussing CCSVI with Doctors
    • Endothelial Health
    • Finding Treatment Providers
    • CCSVI Treatment Aftercare
  • Patient Perspectives
    • Living the Experience
    • Patient Q & A
  • Helping the Cause
    • Donate to CCSVI Alliance
    • Direct Research Funding
    • Creative Giving
    • Workplace Giving
    • Printable Documents
    • Clinical Trials in the US

If I have had CCSVI treatment or if I am considering CCSVI treatment, should I stop taking my disease modifying drugs? (DMDs)

MS patients should consult with their personal physicians regarding all treatment decisions. Note that Dr. Zamboni strongly recommended that all RRMS patients currently on DMDs, who had the CCSVI procedure, remain on their disease modifying drugs. The FDA approved DMDs have been helpful for many patients, and combining DMDs with the CCSVI procedures does not appear to add any additional risk for the patient.


previous  FAQbutton  next


 
Donate | Contact Us | Facebook | Twitter | Sitemap | Terms of Use | Privacy Policy | Login